Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses.

Cancer Cell
Elizabeth StewartSt. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project

Abstract

Personalized cancer therapy targeting somatic mutations in patient tumors is increasingly being incorporated into practice. Other therapeutic vulnerabilities resulting from changes in gene expression due to tumor specific epigenetic perturbations are progressively being recognized. These genomic and epigenomic changes are ultimately manifest in the tumor proteome and phosphoproteome. We integrated transcriptomic, epigenomic, and proteomic/phosphoproteomic data to elucidate the cellular origins and therapeutic vulnerabilities of rhabdomyosarcoma (RMS). We discovered that alveolar RMS occurs further along the developmental program than embryonal RMS. We also identified deregulation of the RAS/MEK/ERK/CDK4/6, G2/M, and unfolded protein response pathways through our integrated analysis. Comprehensive preclinical testing revealed that targeting the WEE1 kinase in the G2/M pathway is the most effective approach in vivo for high-risk RMS.

Citations

Sep 27, 2018·Molecular Omics·Liyuan PengEdouard C Nice
Jan 9, 2019·Nature Reviews. Disease Primers·Stephen X SkapekDouglas S Hawkins
Jun 22, 2019·Pediatric Blood & Cancer·Marielle E YoheDavid M Langenau
Jun 5, 2019·Proteomes·Kenneth R Williams, Angus C Nairn
Aug 17, 2019·Current Molecular Medicine·Sacha Nahon-EstevePaul Hofman
Dec 10, 2019·Current Opinion in Pediatrics·Angelina V Vaseva, Marielle E Yohe
Jul 6, 2019·Journal of Cellular and Molecular Medicine·Hongjuan SongGuilin Li
Jan 11, 2020·Frontiers in Oncology·Celine ChenAnton G Henssen
Jul 23, 2020·F1000Research·Jessica Gartrell, Alberto Pappo
Apr 29, 2020·Nature Immunology·Domenick E KennedyMarcus R Clark
Sep 3, 2020·Proteomics·Giulia MantiniConnie R Jimenez
Dec 21, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kristina A ColeBrenda J Weigel
Sep 11, 2020·Cancer Research·Gina M NeyQing Li
Jan 28, 2021·Technology in Cancer Research & Treatment·Zihang ChenDong-Lai Wang
Feb 3, 2021·Inflammatory Bowel Diseases·Montserrat Baldan-MartinJavier P Gisbert
Nov 17, 2020·Current Oncology Reports·Fiorela N Hernandez TejadaDouglas Harrison
Jul 28, 2020·IScience· Hao ShiJiyang Yu
Jun 11, 2021·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Petros Giannikopoulos, David M Parham
Aug 1, 2021·Cancer Chemotherapy and Pharmacology·Marielle HuotNoël J M Raynal
Aug 26, 2021·Genome Biology·Beisi XuChunliang Li
Aug 22, 2020·Seminars in Cancer Biology·Dieter WeichenhanChristoph Plass

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Revista española de las enfermedades del aparato digestivo
E Romero GonzálezJ Potenciano Mora
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sabine Mueller, Daphne A Haas-Kogan
Nihon rinsho. Japanese journal of clinical medicine
Saori TomitaMitsuyoshi Nakao
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine
R W EDLAND
© 2022 Meta ULC. All rights reserved